Science Strategic Current Valuation vs. Shares Owned by Institutions

SSAA
 Stock
  

USD 9.85  0.01  0.10%   

For Science Strategic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Science Strategic to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Science Strategic Acquisition utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Science Strategic's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Science Strategic Acquisition over time as well as its relative position and ranking within its peers. Additionally, take a look at World Market Map.
  
Is Science Strategic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Strategic. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Strategic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Science Strategic is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Strategic's value that differs from its market value or its book value, called intrinsic value, which is Science Strategic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Strategic's market value can be influenced by many factors that don't directly affect Science Strategic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Science Strategic's value and its price as these two are different measures arrived at by different means. Investors typically determine Science Strategic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Strategic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Science Strategic Shares Owned by Institutions vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Science Strategic's current stock value. Our valuation model uses many indicators to compare Science Strategic value to that of its competitors to determine the firm's financial worth.
Science Strategic Acquisition is currently regarded number one company in current valuation category among related companies. It is currently regarded as top stock in shares owned by institutions category among related companies . The ratio of Current Valuation to Shares Owned by Institutions for Science Strategic Acquisition is about  4,462,150 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Science Strategic by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Science Strategic's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Science Strategic's earnings, one of the primary drivers of an investment's value.

Science Current Valuation vs. Competition

Science Strategic Acquisition is currently regarded number one company in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Shell Companies industry is at this time estimated at about 36.75 Billion. Science Strategic claims roughly 381.96 Million in current valuation contributing just under 2% to equities listed under Shell Companies industry.

Science Shares Owned by Institutions vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Science Strategic 
Enterprise Value 
 = 
Market Cap + Debt 
-  
Cash 
381.96 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Science Strategic 
Shares Held by Institutions 
 = 
Funds and Banks 
Firms 
85.60 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

Science Shares Owned by Institutions Comparison

Science Strategic is currently under evaluation in shares owned by institutions category among related companies.

Science Strategic Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Science Strategic, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Science Strategic will eventually generate negative long term returns. The profitability progress is the general direction of Science Strategic's change in net profit over the period of time. It can combine multiple indicators of Science Strategic, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses in the direct-to-consumer brands, D2C services, and mobile and social entertainment sectors. The company was incorporated in 2020 and is based in Santa Monica, California. Science Strategic is traded on NASDAQ Exchange in the United States.

Science Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Science Strategic. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Science Strategic position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Science Strategic's important profitability drivers and their relationship over time.

Use Science Strategic in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Science Strategic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Science Strategic will appreciate offsetting losses from the drop in the long position's value.

Science Strategic Pair Trading

Science Strategic Acquisition Pair Trading Analysis

The ability to find closely correlated positions to Science Strategic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Science Strategic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Science Strategic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Science Strategic Acquisition to buy it.
The correlation of Science Strategic is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Science Strategic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Science Strategic moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Science Strategic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Science Strategic position

In addition to having Science Strategic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Latest Gainers Thematic Idea Now

Latest Gainers
Latest Gainers Theme
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Gainers theme has 60 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Gainers Theme or any other thematic opportunities.
View All  Next Launch
Additionally, take a look at World Market Map. Note that the Science Strategic information on this page should be used as a complementary analysis to other Science Strategic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Science Stock analysis

When running Science Strategic price analysis, check to measure Science Strategic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science Strategic is operating at the current time. Most of Science Strategic's value examination focuses on studying past and present price action to predict the probability of Science Strategic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Science Strategic's price. Additionally, you may evaluate how the addition of Science Strategic to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
To fully project Science Strategic's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Science Strategic at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Science Strategic's income statement, its balance sheet, and the statement of cash flows.
Potential Science Strategic investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Science Strategic investors may work on each financial statement separately, they are all related. The changes in Science Strategic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Science Strategic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.